Annual EBIT
-$150.27 M
+$26.58 M+15.03%
31 December 2023
Summary:
Esperion Therapeutics annual earnings before interest & taxes is currently -$150.27 million, with the most recent change of +$26.58 million (+15.03%) on 31 December 2023. During the last 3 years, it has fallen by -$29.39 million (-24.31%). ESPR annual EBIT is now -1367.47% below its all-time high of -$10.06 million.ESPR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$14.44 M
+$33.76 M+70.04%
30 September 2024
Summary:
Esperion Therapeutics quarterly earnings before interest & taxes is currently -$14.44 million, with the most recent change of +$33.76 million (+70.04%) on 30 September 2024. Over the past year, it has increased by +$11.81 million (+44.99%). ESPR quarterly EBIT is now -111.17% below its all-time high of $129.25 million, reached on 30 June 2020.ESPR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$28.89 M
+$11.81 M+29.03%
30 September 2024
Summary:
Esperion Therapeutics TTM earnings before interest & taxes is currently -$28.89 million, with the most recent change of +$11.81 million (+29.03%) on 30 September 2024. Over the past year, it has increased by +$121.26 million (+80.76%). ESPR TTM EBIT is now -1219.85% below its all-time high of -$2.19 million, reached on 31 March 2012.ESPR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.0% | +45.0% | +80.8% |
| 3 y3 years | -24.3% | +74.1% | +89.2% |
| 5 y5 years | +25.5% | +77.6% | +68.3% |
ESPR EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -24.3% | +32.5% | -119.2% | +74.1% | -3.5% | +89.2% |
| 5 y | 5 years | -68.8% | +32.5% | -111.2% | +84.9% | -3.5% | +90.1% |
| alltime | all time | -1367.5% | +32.5% | -111.2% | +84.9% | -1219.8% | +90.1% |
Esperion Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$14.44 M(-70.0%) | -$28.89 M(-29.0%) |
| June 2024 | - | -$48.20 M(-164.2%) | -$40.70 M(+45.9%) |
| Mar 2024 | - | $75.05 M(-281.8%) | -$27.89 M(-81.4%) |
| Dec 2023 | -$150.27 M(-15.0%) | -$41.29 M(+57.3%) | -$150.27 M(+0.1%) |
| Sept 2023 | - | -$26.25 M(-25.8%) | -$150.14 M(-8.9%) |
| June 2023 | - | -$35.40 M(-25.2%) | -$164.85 M(-9.2%) |
| Mar 2023 | - | -$47.33 M(+15.0%) | -$181.51 M(+2.6%) |
| Dec 2022 | -$176.85 M(-20.6%) | -$41.16 M(+0.5%) | -$176.85 M(-5.6%) |
| Sept 2022 | - | -$40.96 M(-21.3%) | -$187.38 M(-7.3%) |
| June 2022 | - | -$52.06 M(+22.0%) | -$202.15 M(+10.7%) |
| Mar 2022 | - | -$42.67 M(-17.5%) | -$182.61 M(-18.0%) |
| Dec 2021 | -$222.75 M(+84.3%) | -$51.69 M(-7.3%) | -$222.75 M(-16.4%) |
| Sept 2021 | - | -$55.73 M(+71.4%) | -$266.61 M(-8.5%) |
| June 2021 | - | -$32.52 M(-60.7%) | -$291.39 M(+124.8%) |
| Mar 2021 | - | -$82.81 M(-13.3%) | -$129.61 M(+7.2%) |
| Dec 2020 | -$120.88 M(+35.8%) | -$95.55 M(+18.7%) | -$120.88 M(+45.4%) |
| Sept 2020 | - | -$80.51 M(-162.3%) | -$83.16 M(+24.1%) |
| June 2020 | - | $129.25 M(-274.5%) | -$67.03 M(-73.2%) |
| Mar 2020 | - | -$74.08 M(+28.1%) | -$250.50 M(+181.3%) |
| Dec 2019 | -$89.05 M(-55.9%) | -$57.82 M(-10.2%) | -$89.05 M(-2.4%) |
| Sept 2019 | - | -$64.38 M(+18.7%) | -$91.26 M(+18.8%) |
| June 2019 | - | -$54.22 M(-162.1%) | -$76.79 M(+11.2%) |
| Mar 2019 | - | $87.38 M(-245.5%) | -$69.05 M(-66.0%) |
| Dec 2018 | -$201.78 M(+21.0%) | -$60.04 M(+20.3%) | -$203.32 M(+13.1%) |
| Sept 2018 | - | -$49.91 M(+7.4%) | -$179.79 M(+2.4%) |
| June 2018 | - | -$46.48 M(-0.9%) | -$175.62 M(+1.6%) |
| Mar 2018 | - | -$46.89 M(+28.5%) | -$172.79 M(+3.6%) |
| Dec 2017 | -$166.79 M | -$36.50 M(-20.2%) | -$166.79 M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$45.74 M(+4.8%) | -$159.14 M(+21.7%) |
| June 2017 | - | -$43.66 M(+6.8%) | -$130.72 M(+29.4%) |
| Mar 2017 | - | -$40.89 M(+41.7%) | -$100.99 M(+35.4%) |
| Dec 2016 | -$74.58 M(+51.4%) | -$28.85 M(+66.7%) | -$74.58 M(+27.0%) |
| Sept 2016 | - | -$17.31 M(+24.2%) | -$58.73 M(+8.6%) |
| June 2016 | - | -$13.94 M(-3.7%) | -$54.08 M(+3.2%) |
| Mar 2016 | - | -$14.47 M(+11.3%) | -$52.41 M(+6.4%) |
| Dec 2015 | -$49.26 M(+36.4%) | -$13.00 M(+2.6%) | -$49.26 M(+8.1%) |
| Sept 2015 | - | -$12.67 M(+3.4%) | -$45.59 M(+7.0%) |
| June 2015 | - | -$12.26 M(+8.2%) | -$42.59 M(+7.6%) |
| Mar 2015 | - | -$11.33 M(+21.5%) | -$39.56 M(+9.6%) |
| Dec 2014 | -$36.10 M(+43.5%) | -$9.32 M(-3.6%) | -$36.10 M(-1.0%) |
| Sept 2014 | - | -$9.67 M(+4.7%) | -$36.47 M(+13.8%) |
| June 2014 | - | -$9.24 M(+17.3%) | -$32.04 M(+8.2%) |
| Mar 2014 | - | -$7.87 M(-18.7%) | -$29.61 M(+17.7%) |
| Dec 2013 | -$25.15 M(+145.2%) | -$9.69 M(+85.0%) | -$25.15 M(+42.3%) |
| Sept 2013 | - | -$5.24 M(-23.1%) | -$17.68 M(+14.6%) |
| June 2013 | - | -$6.81 M(+99.7%) | -$15.43 M(+34.4%) |
| Mar 2013 | - | -$3.41 M(+54.0%) | -$11.48 M(+11.9%) |
| Dec 2012 | -$10.26 M(+0.2%) | -$2.21 M(-25.9%) | -$10.26 M(+27.5%) |
| Sept 2012 | - | -$2.99 M(+4.4%) | -$8.04 M(+59.2%) |
| June 2012 | - | -$2.86 M(+30.8%) | -$5.05 M(+130.8%) |
| Mar 2012 | - | -$2.19 M | -$2.19 M |
| Dec 2011 | -$10.24 M(-65.0%) | - | - |
| Dec 2002 | -$29.24 M(-0.3%) | - | - |
| Dec 2001 | -$29.33 M(+6.4%) | - | - |
| Dec 2000 | -$27.57 M(+122.9%) | - | - |
| Dec 1999 | -$12.37 M | - | - |
FAQ
- What is Esperion Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Esperion Therapeutics?
- What is Esperion Therapeutics annual EBIT year-on-year change?
- What is Esperion Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly EBIT year-on-year change?
- What is Esperion Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Esperion Therapeutics?
- What is Esperion Therapeutics TTM EBIT year-on-year change?
What is Esperion Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ESPR is -$150.27 M
What is the all time high annual EBIT for Esperion Therapeutics?
Esperion Therapeutics all-time high annual earnings before interest & taxes is -$10.06 M
What is Esperion Therapeutics annual EBIT year-on-year change?
Over the past year, ESPR annual earnings before interest & taxes has changed by +$26.58 M (+15.03%)
What is Esperion Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ESPR is -$14.44 M
What is the all time high quarterly EBIT for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly earnings before interest & taxes is $129.25 M
What is Esperion Therapeutics quarterly EBIT year-on-year change?
Over the past year, ESPR quarterly earnings before interest & taxes has changed by +$11.81 M (+44.99%)
What is Esperion Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ESPR is -$28.89 M
What is the all time high TTM EBIT for Esperion Therapeutics?
Esperion Therapeutics all-time high TTM earnings before interest & taxes is -$2.19 M
What is Esperion Therapeutics TTM EBIT year-on-year change?
Over the past year, ESPR TTM earnings before interest & taxes has changed by +$121.26 M (+80.76%)